Skip to main content
Erschienen in: Current Treatment Options in Cardiovascular Medicine 10/2018

01.10.2018 | Women’s Health (M Wood, Section Editor)

The Global Burden of Cardiovascular Disease in Women

verfasst von: Shilpa Sharma, MD, Malissa J. Wood, MD

Erschienen in: Current Treatment Options in Cardiovascular Medicine | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for one third of all deaths in 2015. Alarmingly, there has been slowing of the decline in age-standardized CVD mortality over the last 5 years compared to the previous 25 years.

Recent findings

Given the increasing global CVD burden, in 2011, the United Nations declared the goal to reduce premature mortality from the four main non-communicable diseases by 25% from 2010 to 2025, abbreviated as the 25 × 25 goal. The United Nations has further created nine targets to achieve the 25 × 25 goal. These targets emphasize risk factor modification and strengthening of healthcare delivery systems.

Summary

Achieving the nine targets and 25 × 25 goal set by the United Nations will undoubtedly benefit the world as a whole. However, women face additional, unacceptable, disproportionate CVD risk factors that need to be addressed, including psychological stressors contributing to ischemic heart disease, pregnancy-related CVD, environmental and infectious exposures in low socioeconomic settings, and limited healthcare access and delivery. This paper highlights global CVD gender disparities in order to stimulate awareness and discussion of potential interventions to address the rapidly growing burden of heart disease in women.
Literatur
1.
Zurück zum Zitat • Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25. This multinational collaborative research project using a wide spread of resources including country-level surveillance data, verbal autopsies, vital registrations, published and unpublished registries, and published scientific reports provides the most updated and comprehensive estimate of global cardiovascular disease incidence, prevalence, and mortality.PubMedPubMedCentralCrossRef • Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25. This multinational collaborative research project using a wide spread of resources including country-level surveillance data, verbal autopsies, vital registrations, published and unpublished registries, and published scientific reports provides the most updated and comprehensive estimate of global cardiovascular disease incidence, prevalence, and mortality.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667–78.CrossRefPubMed Roth GA, Huffman MD, Moran AE, Feigin V, Mensah GA, Naghavi M, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667–78.CrossRefPubMed
3.
Zurück zum Zitat Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, et al. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation. 2014;129:1493–501.CrossRefPubMedPubMedCentral Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, et al. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation. 2014;129:1493–501.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.CrossRefPubMed Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837–47.CrossRefPubMed
5.
Zurück zum Zitat Kwan GF, Mayosi BM, Mocumbi AO, Miranda JJ, Ezzati M, Jain Y, et al. Endemic cardiovascular diseases of the poorest billion. Circulation. 2016;133:2561–75.CrossRefPubMed Kwan GF, Mayosi BM, Mocumbi AO, Miranda JJ, Ezzati M, Jain Y, et al. Endemic cardiovascular diseases of the poorest billion. Circulation. 2016;133:2561–75.CrossRefPubMed
6.
Zurück zum Zitat Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377:713–22.CrossRefPubMed Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377:713–22.CrossRefPubMed
7.
Zurück zum Zitat Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333–41.CrossRefPubMedPubMedCentral Roth GA, Forouzanfar MH, Moran AE, Barber R, Nguyen G, Feigin VL, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333–41.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, et al. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and western diet in 1980 and 2008. Circulation. 2013;127:1493–502. 1502e1491-1498CrossRefPubMedPubMedCentral Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, et al. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and western diet in 1980 and 2008. Circulation. 2013;127:1493–502. 1502e1491-1498CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat • Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the 25x25 non-communicable disease mortality reduction target: a modelling study. Lancet. 2014;384:427–37. This modeling study highlights the importance of risk factor reduction in reducing cardiovascular disease burden and analyzes, which risk factors should be targeted most aggressively to have the greatest benefit in mortality. The study also points out differences between genders in benefit from risk factor reduction.CrossRefPubMed • Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the 25x25 non-communicable disease mortality reduction target: a modelling study. Lancet. 2014;384:427–37. This modeling study highlights the importance of risk factor reduction in reducing cardiovascular disease burden and analyzes, which risk factors should be targeted most aggressively to have the greatest benefit in mortality. The study also points out differences between genders in benefit from risk factor reduction.CrossRefPubMed
10.
Zurück zum Zitat O'Neil A, Scovelle AJ, Milner AJ, Kavanagh A. Gender/sex as a social determinant of cardiovascular risk. Circulation. 2018;137:854–64.CrossRefPubMed O'Neil A, Scovelle AJ, Milner AJ, Kavanagh A. Gender/sex as a social determinant of cardiovascular risk. Circulation. 2018;137:854–64.CrossRefPubMed
11.
Zurück zum Zitat von Dadelszen P, Magee LA. Strategies to reduce the global burden of direct maternal deaths. Obstet Med. 2017;10:5–9.CrossRef von Dadelszen P, Magee LA. Strategies to reduce the global burden of direct maternal deaths. Obstet Med. 2017;10:5–9.CrossRef
12.
Zurück zum Zitat Krieger EV, Stout KK. Progress: the ROPAC multinational registry advances our understanding of an important outcome in pregnant women with heart disease. Heart. 2014;100:188–9.CrossRefPubMed Krieger EV, Stout KK. Progress: the ROPAC multinational registry advances our understanding of an important outcome in pregnant women with heart disease. Heart. 2014;100:188–9.CrossRefPubMed
13.
14.
Zurück zum Zitat Kandasamy S, Anand SS. Cardiovascular disease among women from vulnerable populations: a review. Can J Cardiol. 2018;34:450–7.CrossRefPubMed Kandasamy S, Anand SS. Cardiovascular disease among women from vulnerable populations: a review. Can J Cardiol. 2018;34:450–7.CrossRefPubMed
15.
Zurück zum Zitat • Chow CK, Patel AA. Women’s cardiovascular health in India. Heart. 2012;98:456–9. This manuscript provides an in-depth analysis of women’s heart disease in India and disparities between genders. Although focused on India, the findings are representative of many low- and middle-income countries.CrossRefPubMed • Chow CK, Patel AA. Women’s cardiovascular health in India. Heart. 2012;98:456–9. This manuscript provides an in-depth analysis of women’s heart disease in India and disparities between genders. Although focused on India, the findings are representative of many low- and middle-income countries.CrossRefPubMed
16.
Zurück zum Zitat Zhao M, Vaartjes I, Graham I, Grobbee D, Spiering W, Klipstein-Grobusch K, et al. Sex differences in risk factor management of coronary heart disease across three regions. Heart. 2017;103:1587–94.CrossRefPubMedPubMedCentral Zhao M, Vaartjes I, Graham I, Grobbee D, Spiering W, Klipstein-Grobusch K, et al. Sex differences in risk factor management of coronary heart disease across three regions. Heart. 2017;103:1587–94.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource effective strategies to prevent and treat cardiovascular disease. Circulation. 2016;133:742–55.CrossRefPubMedPubMedCentral Schwalm JD, McKee M, Huffman MD, Yusuf S. Resource effective strategies to prevent and treat cardiovascular disease. Circulation. 2016;133:742–55.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34.CrossRefPubMed Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624–34.CrossRefPubMed
19.
Zurück zum Zitat Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, et al. The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation. 2016;133:e674–90.CrossRefPubMed Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, et al. The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation. 2016;133:e674–90.CrossRefPubMed
Metadaten
Titel
The Global Burden of Cardiovascular Disease in Women
verfasst von
Shilpa Sharma, MD
Malissa J. Wood, MD
Publikationsdatum
01.10.2018
Verlag
Springer US
Erschienen in
Current Treatment Options in Cardiovascular Medicine / Ausgabe 10/2018
Print ISSN: 1092-8464
Elektronische ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-018-0676-1

Weitere Artikel der Ausgabe 10/2018

Current Treatment Options in Cardiovascular Medicine 10/2018 Zur Ausgabe

Sports Imaging (M Papadakis, Section Editor)

Assessment of the QT Interval in Athletes: Red Flags and Pitfalls

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.